Skip to main content

Table 1 Baseline demographic and clinical characteristics in individuals with and without glycemic impairment at baseline

From: Circulating micrornas associated with glycemic impairment and progression in Asian Indians

Characteristics Mean ± SD, Median (IQR), or n (%)

Glycemic Impairment (n = 73)

Normal Glycemia (n = 55)

p-value

Sex (male)

29 (40)

18 (33)

0.002

Age (years)

56 ± 9

57 ± 7

0.897

Current Smokers

3 (4)

3 (5)

0.386

Physical Activity (MET-minutes/week)

1313 (585, 2940)

1365 (683, 2333)

0.942

Systolic Blood Pressure (mm Hg)

127 ± 15

117 ± 16

<0.001

Diastolic Blood Pressure (mm Hg)

75 ± 12

69 ± 9

0.002

Total Cholesterol (mg/dL)

191 ± 33

194 ± 31

0.683

LDL-c (mg/dL)

116 ± 31

117 ± 27

0.731

HDL-c (md/dL)

47 ± 13

53 ± 15

0.016

Triglycerides (mg/dL)

146 ± 72

115 ± 39

0.006

Fasting Blood Glucose (mg/dL)

105 ± 21

87 ± 6

<0.001

Insulin (μIU/mL)

15 ± 11

10 ± 5

0.001

HOMA-IR (μIU/mL*mmol/L)

4.1 ± 3.4

2.2 ± 1.1

<0.001

Body Mass Index (kg/m2)

26.9 ± 5.1

24.7 ± 3.6

0.006

Waist Circumference (cm)

98 ± 13

91 ± 11

0.003

  1. cm centimeters, HDL-c high density lipoprotein cholesterol, HOMA-IR homeostasis model assessment-insulin resistance, kg/m 2 kg per meter2, LDL-c low density lipoprotein cholesterol, mcU/mL microUnit per milliliter, mg/dL milligrams per deciliter, mm Hg millimeters of mercury, SD standard deviation